Philip Morris
Fields
- Type
- SPCH, SPEECH, PRESENTATION
- BUDG, BUDGET, BUDGET REVIEW
- Area
- LEGAL DEPT/100 PARK FILE ROOM
- Characteristic
- MARG, MARGINALIA
- Named Organization
- American Journal of Epidemiology
- American Journal of Public Health
- Cancer Society
- Columbia
- Comparison Groups
- Ctr, Council for Tobacco Research
- Duke Univ
- Harvard Medical School
- Intl Journal of Epidemiology
- Johns Hopkins
- Journal of the Natl Cancer Inst
- Medical College of Va
- Mehari Medical College
- Mrfit
- Mt Sinai
- New England Journal of Medicine
- NIH, Natl Inst of Health
- Ny Medical College
- Psychology Today
- RJR, R.J.Reynolds
- Treatment Group
- Univ of NC
- Univ of Rochester
- American Journal of Public Health
- Named Person
- Ader, R.
- Cullman, H.
- Eaves, L.
- Eysenck, H.
- Framingham
- Friedman, M.
- Grossarthmaticek
- Gutstein, W.
- Holtzman, A.
- Houghton, K.
- Murray, W.
- Oshea, M.
- Stein, M.
- Thomas, J.
- Williams, R.
- Wynder, E.
- Cullman, H.
- Document File
- 2023038165/2023038344/PM Research Program Review 900000
- Litigation
- Stmn/Produced
- Master ID
- 2023038166/8343
Related Documents:- 2023038166
- 2023038167 Philip Morris Support for Basic Research
- 2023038168-8171 Summary of Discussion Regarding Support for Basic Research
- 2023038172-8202 Curriculum Vitae Richard Alan Lerner, M.D.
- 2023038203-8214 Curriculum Vitae Gerald M. Edelman
- 2023038215-8217
- 2023038218-8219 Gerald Maurice Edelman A Biological Sketch
- 2023038220
- 2023038221 Richard A. Cramer
- 2023038222-8228 William H. Beers 6436 Avenida Cresta La Jolla, Ca 92037
- 2023038229 Arthur J. Benvenuto Biography
- 2023038230-8232 Biographical Sketch Ames S. Early
- 2023038233-8236 Curriculum Vitae Charles C. Edwards, M.D.
- 2023038237-8240 James C. Gaither Career Summary
- 2023038242-8245 Background William E. Nelson
- 2023038246 David S. Tappan Jr. 910200 Biography
- 2023038247-8251 Alejandro Zaffaroni, Ph.D. 910823 Biography
- 2023038252
- 2023038253-8259 A Research Institute
- 2023038260 Notice the Difference and You Will Change Your View About Smoking
- 2023038261
- 2023038266 Philip Morris Research
- 2023038271
- 2023038283 Physical Research
- 2023038284
- 2023038285-8289 Conf T. Osdene / Bob Pages
- 2023038290-8291
- 2023038293-8295 Art Support
- 2023038296-8297 Research Program Review
- 2023038298-8299 Research Projects in 900000, in Vivo Studies
- 2023038300
- 2023038301
- 2023038302-8309 Internal Reports Issued by the Research and Development Department Period Covered: 891215 - 900228 Volume 6, Issue 1
- 2023038310 Research Program Review
- 2023038311 Research Program Review - Richmond R&D
- 2023038312-8327
- Site
- N28
- Date Loaded
- 31 Jan 1999
- UCSF Legacy ID
- nck53e00
Document Images
PRESENTATION
May 25, 1989
~
:ist,
ci

-2-
To reset the stage I will define the mission as trying
to contribute to the scientific defense of the industry.
The assumption is that we remain vulnerable unless we can
break down the near unanimity in the medical research
community that cigarette smoking causes several hundred
thousand premature deaths a year in the United States alone.
While the only certainty is that there will be no quick
and easy victory, we can defend ourselves along two general
lines. The first is to pound away at the flaws in the case
against us, that we have known of for years. Good science
demands that an explanation fit all the known facts.
Unfortunately for us scientists and physicians do not always
live up to this standard. Thus the importance of the other
line of defense - establishing non-smoking explanations for
the average premature mortality of smokers, and, to the
extent possible, for the skewing of their terminal illnesses
towards respiratory diseases, particularly lung cancer.
d'6x ternal_projects th t involve funding outsiders.
Our activities can be dividec ~into internal projects
that are our own attempts to originate publishable material
Paradoxically our first internal project resulted in
the publication by Ernst Wynder and two associates of an
article in the Journal of the National Cancer Institute
entitled Association of Dietary Fat and Lung Cancer. It
reported international correlation data I had begun
developing when I was still the Planning officer, but had
long been unsuccessful in getting even our friends to
N
O
AN
CJ
0
W
M
CJ
N
CO

r
-3-
listen to. We thought we had spotted a strategy to get it
published over our own names but Hugh Cullman then suggested
the material would have more impact if Dr. Wynder could be
persuaded to present it.
The result was not nearly as kind to tobacco as it
could have been. It was written to give the typical reader
the impression smoking and dietary fat contributed equally
to accounting for the international variations in male lung
cancer, when in truth, dietary fat was a significant
independent contributor and smoking was not. However, I'm
sure Hugh was right. It was worth the sacrifice to have
Wynder be the one to put dietary fat into play in regard to
lung cancer. Furthermore his more honest and statistically
knowledgeable henchman included (possibly without Dr. Wynder
realizing their significance) statements and data sufficient
to reveal the truth to the minority of readers who were
familiar with the most appropriate statistical methods. The
Wynder article is the first item in the folders.
When another published study showing a protective
relat~onship between vitamin A and lung cancer also revealed
data indicating a predictive relationship between fat and
lung cancer, I persuaded Dr. Wynder's associate to write a
Letter to the Editor pointing out that the study's authors
had not given appropriate emphasis to the fat-lung cancer
relationship. That's item #2 in your folder.
Also in the folder is a Letter from us to the Editor
of the International Journal of Epidemiology correcting an
~
~
w
0
Cj
ga°
w
0

...... . .. . ., .......a........~«_... _.a.....:..:.t ..~_....t.. . .......... ... .~,.J
.:.t+:.,........2.t:i.:...[.t.i.eS .... i.e.....i.. .t.aS{;.... ,t. ..,., ...u. .__...,. .
,1,1,t..,.,~j....
-4-
understatement of the relationship of fat to lung cancer in
a population study they had published.
Two passive smoking Letters have published over our
signatures. Incidentally, our submissions are cleared in
advance with Alex Holtzman.and whoever is mv current boss
Full scale manuscripts are also reviewed by Ken Houghton.
The first letter was to the Editor of the American Journal
of Public Health, criticizing a passive smoking study it had
reported. We claimed that stress could be the underlvincr
~ - _
cause of an association between passive smoking and lung
cancer. The editor took a dim view of our position telling
us, and I quote, "'it is a long leap from coronary diseases
and hypertension to cancer" and "Even in the case of heart
disease, studies on its relation to stress have yielded
conflicting results". When he could not talk us into
withdrawing, he did publish along with the authors' reply.
They agreed with our contention that in the current climate
the non-smoking marriage partner was stressed by fears the
smoking partner was engaging in self-destructive behavior.
As the editor had predicted they aimed their fire at our
connection of stress with lung cancer. The correspondence
is in your folders. (Item 4)
In a Letter to the Editor of the American Journal of
Epidemiology, criticizing on the same stress basis another
passive smoking study, one that got the same silly answer
recently printed about cervix cancer, we went beyond passive
smoking in our final two paragraphs and defended active

-5-
smoking, as well. We included the industry's standard point
that their smoking habits are not the only relevant
differences between smokers and non-smokers. We also
introduced the thought that it is harmfully stressful to the
active smoker to be constantly told smoking is self
destructive; and the thought that smoking cessation may have
a placebo effect. These latter points were original
thinking with me, although experience has taught me that
what one believes to be original is sometimes unconscious
recall of unoriginal ideas. The authors declined to reply
to this letter and the editor added a footnote pointing-up
their failure to accept that opportunity. Our letter in the
folders.
With regard to the placebo effect of smoking cessation,
I should mention another point we have not even tried to
publish, because I have not yet figured out how to document
it. It could be part of the real explanation of the
benefits smoking cessation appears to confer. Experienced
doctors and nurses will tell you that some patients have a
to~live than others that is not always
stroncer wil]t_
recognizable in interviews. I believe a climate has been
created in which i~ixidtjals xjth a strona wi_ 11 to live are
more likelv to give up smoking than those whose will to live
is weaker.
We have also published a Letter in the New England
Journal of Medicine, seizing another opportunity to present
the same defense for active smoking that appeared in our

-6-
American Journal of Epidemiology letter. This time the
authors replied that our arguments were "absurd" and
justified this dismissal by referencing a 1987 Government
publication that reiterated the conventional wisdom about
smoking. While we have no way of knowing if our arguments
impressed any of the journal's readers, we think that reply
was unlikely to affect their appraisal of our points. (item 6)
We have published one Letter relating to what I call
the "reverse hypothesis", namely that individuals with lung
problems may be disproportionately likely to en`oy the
satisfactions of smoking; thus producing an association
between smokina and luna problems that is not causa] Our
best data in support of that hypothesis is quite old so we
played our Letter off a recent article that provided much
weaker support. The authors' reply jumped all over our weak
peg but did not challenge the underlying idea or the strong
data that supported it. (Item 7)
We have had two Letters rejected, making us five for
seven, to date. On free-standing articles we are 0 for 1.
The reiected manuscript was a wir3~ rangincr summary of points
favorable to the industry. The emphasis in the rejection
was that our piece was one-sided. There were also a number
of other criticisms, many of which were factually incorrect.
The manuscript, the rejection letter and our response to the
rejection letter, are all in the folders. (Items 8-10) We
were more hopeful of continuing the debate than of getting
N
N
W
O
W
00
W
Ci
Ci
them to reverse themselves and print the article, but they

-7-
declined declined even that opportunity. We intend to rework the
broad aaua manuscript and submit it to another iournal
- - ~~
We have submitted a second, more narrowly focused
free-stander to another journal. It puts forward our
version of the comparative importance of dietary fat and
tobacco usage in accountin for int rna ional variations in
1unQ cancer. Based on the criticism of the first
free-stander, we built a framework of academic detachment
around our conclusion. No verdict yet. It is the last item
in the folders.
One point about the rejection letter on the first
free-stander, that I now want to emphasize, is that we saw
again that the battleship admirals of medical research are
not yet ready to accept psychosocial stresses as
significant contributors to mortality. Our contention,
that psychosocial factors would turn out to be key
determinants of longevity was dismissed by one of the
reviewers as "trite pop-psychology", even though we
supported it by quoting an epidemiologist from a major
university.
This leads me smoothly, I hope, to our external
funding which is aimedt almost entirel at promoting_they_
role of psvchosociaI sssPg in mortality. This seems by
O
N
0
W
far the most promising area for us at this time. Genetic 0
W
determinants of survival are also important but twin studies
have forced abandonment of the retrospectively unrealistic ~
G?
W
hope they would provide full exoneration. ~

-8-
Much of our funding is related to establishing the
independent importance of the psychosocial factors. Until
that is more widely accepted, it will be difficult to gain
acceptance for evidence that controlling for such factors
reduces or eliminates associations between smoking and
health. Another way of looking at the value of researching
the psychosocial effects, independent of smoking, is that
mortality is a zero sum game. As more is attributable to
one factor, less remains to be attributed to others.
We have also supported projects that have the
possibility of combining psychosocial factors and the
conventional "'risk" factors ~n ~ YDlanatory models that
will allow the psychosocial effects to reduce or eliminate
the associational relationship between smokinQ and_
mortality. One such project that came from Harvard Medical
School some years ago, and that we had nothing to do with,
showed that controlling for psychologic health, left an
insignificant relationship between smoking and subsequent
physical health. Admittedly it was a small project and the
author.claimed that if it had been larger andlor gone on
longer, the results would have been different. Nevertheless,
it was an encouraging result, and I should add it did have
some CTR support. There is also data from the Framingham
study, unfortunately confined to cardiovascular mortality,
indicating that controlling for psychosocial variables
eliminates the significance of smoking.

-9-
To be specifi ~ut--rou de funding we have given
general sup rt to Dr._Robert__Ade the University of
- __
~---. . __---------- --
~~~ Rochester - ad to_Dr- Marvin ' Mt Sinai, two of the
pioneering figures in documenting the role of the
psychosocial factors. Dr. Ader will soon publish an article
demonstrating that just the way animals are handled affects
the metastasizing of tumors to the lungs. Metastasizing, as
you know, is the most lethal aspect of cancer. Dr. Stein's
recent research does not appear to have produced any
exciting end products.
Recently Bill~a 'orized about $1 million over three
years, f,, r Dr.William~ Gutste~f New York Medical College.
"L __ ~-_
Dr. Gutstein has already published evidence that simulated
stress damages coronary arteries in rats. He has also
published indications that cell proliferation may be the
first stage in that damage process. He will now work with
humans to try to establish that stress can be related to a
blood protein involved in this cell proliferation. He wi11
,. -
also investigate whether the stress-cell proliferation
connection can be related to lung tissue.
-~
Johns Hopkin~_js conducting a continuing study of the
` -.... -
health and survival of its classes of 1948 through '64.
Much physical and mental health data was taken while the
subjects were in school. They have about a thousand
subjects, over five times as many as the Harvard study. A
number of papers have already been based upon it. We have
funded two additional projects. The first is titled

4/
-10-
Youthful Predictors of Premature Mortality. The second is
tentatively called Temperament and Other Factors Relating to
Premature Mortality--.
Unfortunately the principal investigator on the first
study is known to be a slow publisher even under ordinary
circumstances; and two special events have had a retarding
effect. One of his co-investigators died in an accident;
and he left Johns Hopkins to accept a full professorship at
Columbia. I cannot tell when the write-up of this study
will be submitted. Hopefully it will be before the end of
this year and publication before the end of next year.
The second study will differ from the first mainly by
incorporating information acquired after the subjects'
left school. While it was started a year later than the
first, it has a different principal investigator who is not
distracted by a new post. It may be ready to be submitted
for publication before the end of this year.
Our largest funding to date, $5 million of endowment
grants over five years, has gone to the Behavioral Medicine
~sQarch Center of Duke University,_headed by Dr. Redford
Williams. Dr. Williams is an aggressive champion of the
idea that psvchosocial factors have a profound influence on
surv _1. He emphasizes that individuals who react to life
experiences with hostility and cynicism are prone to
premature mortality. He is now in the early stages of a
major mortality study that will include a lot more
psychosocial data than the Cancer Society studies have
